ðŠ COVID-19ãšé«éœ¢è ã®å¥åº·ãå®ããã«ã¹ãªãã©ã·ãŒ
äžçäžã§çåšãæ¯ãã£ãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã¯ãç¹ã«é«éœ¢è ã«ãšã£ãŠæ·±å»ãªå¥åº·ãªã¹ã¯ããããããŸãããææçãã身ãå®ãããã«ã¯ãæ£ç¢ºãªç¥èã«åºã¥ããé©åãªäºé²è¡åãäžå¯æ¬ ã§ããããããæ å ±éå€ã®æä»£ã«ãããŠãä¿¡é Œã§ããæ å ±ãèŠæ¥µãããããèªèº«ã®è¡åã«çµã³ã€ããããšã¯å®¹æã§ã¯ãããŸãããããã§éèŠãšãªãã®ãããã«ã¹ãªãã©ã·ãŒãã§ãã
ãã«ã¹ãªãã©ã·ãŒãšã¯ãå¥åº·ã«é¢ããæ å ±ãå ¥æããçè§£ããè©äŸ¡ããæŽ»çšããèœåãæããŸãããã®èœåãé«ãã»ã©ã人ã ã¯ããè¯ãå¥åº·ç¶æ ãç¶æãããããªããšèšãããŠããŸããæ¬èšäºã§ã¯ãã¿ã€ã®ãã³ã³ã¯ã§è¡ããããé«éœ¢è ã察象ãšãããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ããCOVID-19ãžã®æèãšäºé²è¡åã«ã©ã®ãããªåœ±é¿ãäžããã®ããæ€èšŒããç ç©¶ã«ã€ããŠè©³ããã玹ä»ããŸãã
ãã®ç ç©¶ã¯ãéœåžéšã«äœãé«éœ¢è ãããã«ããŠææçãã身ãå®ããããããŠå°å瀟äŒããã®ããã«ã©ã®ãããªæ¯æŽãã§ãããã«ã€ããŠã貎éãªç€ºåãäžããŠãããŸãã
ð¬ ç ç©¶ã®ç®çãšæ¹æ³
ç ç©¶ã®èæ¯ãšç®ç
COVID-19ãã³ãããã¯ã¯ãäžçäžã®å ¬è¡è¡çã·ã¹ãã ã«å€§ããªèª²é¡ãçªãã€ããŸãããç¹ã«é«éœ¢è ã¯éçåãªã¹ã¯ãé«ããææäºé²ã®ããã®é©åãªç¥èãšè¡åãåŒ·ãæ±ããããŸãããããããé«éœ¢è ã®äžã«ã¯ãå¥åº·æ å ±ãžã®ã¢ã¯ã»ã¹ãéãããŠããããè€éãªæ å ±ãçè§£ããã®ãé£ããã£ããããå ŽåããããŸãããã®ãããªç¶æ³ãæ¹åããé«éœ¢è èªèº«ãCOVID-19ãã身ãå®ãèœåãé«ããããã«ããã«ã¹ãªãã©ã·ãŒã®åäžãéèŠèŠãããŸããã
æ¬ç ç©¶ã¯ãã¿ã€ã®ãã³ã³ã¯ã«ããéœåžéšã®å°å瀟äŒã«äœãé«éœ¢è ã察象ã«ããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ãCOVID-19ã«é¢ããæèãšäºé²è¡åãæ¹åããäžã§ã©ãã»ã©å¹æçã§ããããæ€èšŒããããšãç®çãšããŸããã
ç ç©¶ãã¶ã€ã³ãšå¯Ÿè±¡è
ãã®ç ç©¶ã¯ãæºå®éšç ç©¶ããšããææ³ãçšããŠè¡ãããŸãããããã¯ãç 究察象è ãå®å šã«ã©ã³ãã ã«ã°ã«ãŒãåããããã©ã³ãã 忝èŒè©Šéšããšã¯ç°ãªããæ¢åã®ã°ã«ãŒããæ¡ä»¶ã«åºã¥ããŠä»å ¥çŸ€ãšå¯Ÿç §çŸ€ãèšå®ããç ç©¶ãã¶ã€ã³ã§ããä»åã®ç ç©¶ã§ã¯ããã³ã³ã¯ã®ãã¥ã·ããå°åºã«äœãé«éœ¢è 76åã察象ãšãªããŸããããããã®åå è ã¯ããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ãåãããä»å ¥çŸ€ããšãéåžžã®ã±ã¢ãåãããå¯Ÿç §çŸ€ãã«ãããã38åãã€åããããŸããã
ãã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ã®å 容
ä»å ¥çŸ€ã«æäŸããããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ã¯ãPengjuntræ°ãæå±ãããVååãã«ã¹ãªãã©ã·ãŒã¢ãã«ãã«åºã¥ããŠèšèšãããŸããããã®ã¢ãã«ã¯ããã«ã¹ãªãã©ã·ãŒã以äžã®6ã€ã®éèŠãªé åã«åããŠæããŠããŸãã
- ã¢ã¯ã»ã¹ïŒAccessïŒïŒå¥åº·ã«é¢ããæ å ±ãã©ããããã©ã®ããã«å ¥æãããã
- çè§£ïŒUnderstandingïŒïŒå ¥æããæ å ±ãæ£ç¢ºã«çè§£ããèœåã
- 察話çã³ãã¥ãã±ãŒã·ã§ã³ïŒInteractive CommunicationïŒïŒå»çåŸäºè ãä»è ãšå¥åº·ã«ã€ããŠå¹æçã«è©±ãåãèœåã
- æææ±ºå®ïŒDecision-makingïŒïŒçè§£ããæ å ±ã«åºã¥ããŠãèªèº«ã®å¥åº·ã«é¢ããé©åãªæ±ºå®ãäžãèœåã
- è¡åå€å®¹ïŒBehavior ChangeïŒïŒæææ±ºå®ã«åºã¥ããå¥åº·çãªè¡åãå®è·µããç¶ç¶ããèœåã
- ã¢ããã«ã·ãŒïŒAdvocacyïŒïŒèªèº«ã®å¥åº·ã ãã§ãªããä»è ã®å¥åº·ã瀟äŒå šäœã®å¥åº·æ¹åã®ããã«å£°ãäžããèœåã
ãã®ããã°ã©ã ã¯ããããã®é åãç¶²çŸ ããããã«ãå€è§çãªæ¹æ³ã§å®æœãããŸãããå ·äœçã«ã¯ãåå è ãéãŸã£ãŠåŠã¶ãã°ã«ãŒãã»ãã·ã§ã³ããã¹ããŒããã©ã³ã¢ããªãLINEããæŽ»çšããæ å ±å ±æãã³ãã¥ãã±ãŒã·ã§ã³ãå°åå šäœã§å¥åº·ã«é¢ããæèãé«ãããå°å掻åãããããŠåå¥ã®ããŒãºã«å¯Ÿå¿ããããã®ãå®¶åºèšªåããªã©ãçµã¿åããããŸãããããã«ãããé«éœ¢è ãããŸããŸãªåœ¢ã§å¥åº·æ å ±ã«è§Šããçè§£ãæ·±ããè¡åã«ç§»ããããæ¯æŽãè¡ãããŸããã
ããŒã¿åéãšåæ
ããã°ã©ã ã®å¹æãè©äŸ¡ããããã«ãåå è ããã¯3ã€ã®ç°ãªãæç¹ã§ããŒã¿ãåéãããŸããã
- äºåãã¹ãïŒããŒã¹ã©ã€ã³ïŒïŒããã°ã©ã éå§å
- äºåŸãã¹ãïŒããã°ã©ã çµäºçŽåŸïŒ4é±éåŸïŒ
- 远跡調æ»ïŒããã°ã©ã çµäºãããã°ããçµã£ãæç¹ïŒ12é±éåŸïŒ
ãããã®æç¹ã«ãããŠãåå è ã®COVID-19ã«é¢ããæèãšäºé²è¡åã«ã€ããŠã質å祚ãçšããŠæ å ±ãåéãããŸãããåéãããããŒã¿ã¯ããç·åœ¢æ··å广ã¢ãã«ããšããçµ±èšææ³ãçšããŠåæãããŸããããã®ææ³ã¯ãæéã®çµéãšãšãã«å人å ã§ã©ã®ããã«å€åããã£ããããŸãã°ã«ãŒãéã§ã©ã®ãããªéãããã£ããã詳现ã«è©äŸ¡ããã®ã«é©ããŠããŸãã
ð ããã°ã©ã ã®å¹æïŒäž»ãªçµæ
ãã®ãã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ããé«éœ¢è ã®COVID-19ãžã®æèãšäºé²è¡åã«ã©ã®ãããªåœ±é¿ãäžããã®ãããã®äž»èŠãªçµæã衚ã«ãŸãšããŸããã
| è©äŸ¡é ç® | è©äŸ¡æç¹ | ä»å ¥çŸ€ãšå¯Ÿç §çŸ€ã®æ¯èŒ | ä»å ¥çŸ€å ã®å€å |
|---|---|---|---|
| COVID-19æèã¹ã³ã¢ | äºåŸãã¹ãïŒ4é±éåŸïŒ | ä»å ¥çŸ€ãå¯Ÿç §çŸ€ããææã«é«ãã¹ã³ã¢ïŒp < .001ïŒ | äºåãã¹ããšæ¯èŒããŠææãªæ¹å |
| COVID-19äºé²è¡åã¹ã³ã¢ | äºåŸãã¹ãïŒ4é±éåŸïŒ | ä»å ¥çŸ€ãå¯Ÿç §çŸ€ããææã«é«ãã¹ã³ã¢ïŒp < .001ïŒ | äºåãã¹ããšæ¯èŒããŠææãªæ¹å |
| COVID-19æèã¹ã³ã¢ | 远跡調æ»ïŒ12é±éåŸïŒ | ä»å ¥çŸ€ãå¯Ÿç §çŸ€ããææã«é«ãã¹ã³ã¢ïŒp < .001ïŒ | äºåãã¹ããšæ¯èŒããŠææãªæ¹åãç¶æ |
| COVID-19äºé²è¡åã¹ã³ã¢ | 远跡調æ»ïŒ12é±éåŸïŒ | ä»å ¥çŸ€ãå¯Ÿç §çŸ€ããææã«é«ãã¹ã³ã¢ïŒp < .001ïŒ | äºåãã¹ããšæ¯èŒããŠææãªæ¹åãç¶æ |
â»p < .001ïŒçµ±èšåŠçã«éåžžã«ææãªå·®ãããããšã瀺ããŸããããã¯ãå¶ç¶ã«ãã®ãããªçµæãåŸããã確çã0.1%æªæºã§ããããšãæå³ããããã°ã©ã ã®å¹æãéåžžã«ä¿¡é Œã§ããããšã瀺åããŠããŸãã
ãã®çµæããããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ãåããä»å ¥çŸ€ã¯ãããã°ã©ã çµäºçŽåŸã®äºåŸãã¹ãã ãã§ãªãã3ã¶æåŸã®è¿œè·¡èª¿æ»ã«ãããŠããCOVID-19ã«é¢ããæèãšäºé²è¡åã®äž¡æ¹ã«ãããŠãå¯Ÿç §çŸ€ãããææã«é«ãã¹ã³ã¢ã瀺ããããšãæããã«ãªããŸããããŸããä»å ¥çŸ€å ã§ã¯ãããã°ã©ã éå§åãšæ¯èŒããŠãæèãšè¡åãå€§å¹ ã«æ¹åãããã®å¹æãæç¶ããŠããããšã確èªãããŸããã
ð¡ ç ç©¶çµæããèŠããŠããããš
ãã®ç ç©¶çµæã¯ããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ããé«éœ¢è ã®COVID-19ãžã®æèãé«ããå ·äœçãªäºé²è¡åãä¿ãäžã§éåžžã«å¹æçã§ããããšãæç¢ºã«ç€ºããŠããŸããç¹ã«æ³šç®ãã¹ãã¯ããã®å¹æãããã°ã©ã çµäºåŸãæç¶ããç¹ã§ããããã¯ãäžæçãªç¥èã®æäŸã«çãŸãããåå è ã®è¡åå€å®¹ãä¿ãããããç¿æ £ãšããŠå®çããå¯èœæ§ã瀺åããŠããŸãã
ãªãããã°ã©ã ã¯å¹æçã ã£ãã®ãïŒ
ããã°ã©ã ãæåããèŠå ãšããŠã¯ã以äžã®ç¹ãèããããŸãã
- å€é¢çãªã¢ãããŒãïŒã°ã«ãŒãã»ãã·ã§ã³ãLINEãå°å掻åãå®¶åºèšªåãšãã£ã倿§ãªæ¹æ³ãçµã¿åãããããšã§ãåå è ã¯èªèº«ã®åŠç¿ã¹ã¿ã€ã«ãçæŽ»ç°å¢ã«åãããŠæ å ±ã«è§Šããããšãã§ããŸãããããã«ãããããå€ãã®é«éœ¢è ãããã°ã©ã ã«åå ãããããªããçè§£ãæ·±ããããšãã§ãããšèããããŸãã
- Vååãã«ã¹ãªãã©ã·ãŒã¢ãã«ã®æŽ»çšïŒãã¢ã¯ã»ã¹ããããã¢ããã«ã·ãŒããŸã§ããã«ã¹ãªãã©ã·ãŒã®6ã€ã®åŽé¢ãç¶²çŸ ããå æ¬çãªã¢ãããŒãããåãªãç¥èã®äŒéã«çµããããåå è ã®æææ±ºå®èœåãè¡åå€å®¹èœåãç·åçã«é«ããããšã«è²¢ç®ããŸããã
- è¡åå€å®¹ãžã®åãããïŒåã«æ å ±ãæäŸããã ãã§ãªãããããã©ã®ããã«å®çæŽ»ã«æŽ»ããããå ·äœçãªäºé²è¡åãã©ã®ããã«å®è·µãããã«ã€ããŠãç¶ç¶çãªæ¯æŽãšåŒ·åãè¡ãããããšããå¹æã®æç¶ã«ã€ãªãã£ããšèããããŸãã
- å°åããŒã¹ã»çè·åž«äž»å°ã®ä»å ¥ïŒå°åã«æ ¹ãããæŽ»åã§ããããã€çè·åž«ãäž»å°ããããšã§ãåå è ã¯ãã身è¿ã§ä¿¡é Œã§ãããµããŒããåããããšãã§ããŸãããçè·åž«ã¯å¥åº·æè²ã®å°éå®¶ã§ãããåã ã®é«éœ¢è ã®å¥åº·ç¶æ ãããŒãºã«å¿ãããã现ãããªæ¯æŽãæäŸã§ãããšèããããŸãã
ä»åŸã®å ¬è¡è¡çãžã®ç€ºå
ãã®ç ç©¶ã¯ãéœåžéšã«äœãé«éœ¢è ã®å¥åº·å¢é²ã«ãããŠãçè·åž«ãäž»å°ããå°åããŒã¹ã®ãã«ã¹ãªãã©ã·ãŒä»å ¥ãéåžžã«æå¹ãªæŠç¥ãšãªãåŸãããšã瀺ããŠããŸããCOVID-19ã®ãããªææçã ãã§ãªããç³å°¿ç ãé«è¡å§ãªã©ã®æ ¢æ§çŸæ£ç®¡çããããã¯å¥åº·å¯¿åœã®å»¶äŒžãšãã£ãå¹ åºãå ¬è¡è¡çã®èª²é¡ã«å¯ŸããŠããåæ§ã®ã¢ãããŒããå¿çšã§ããå¯èœæ§ããããŸãã
ç¹ã«ãããžã¿ã«ããŒã«ïŒLINEãªã©ïŒã®æŽ»çšã¯ãçŸä»£ç€ŸäŒã«ãããŠé«éœ¢è ãžã®æ å ±æäŸãã³ãã¥ãã±ãŒã·ã§ã³ãå¹ççã«è¡ãäžã§éèŠãªææ®µãšãªãã§ããããå°å瀟äŒå šäœã§é«éœ¢è ã®ãã«ã¹ãªãã©ã·ãŒãé«ããåãçµã¿ã¯ãå人ã®å¥åº·ã ãã§ãªããå°åå šäœã®å¥åº·ã¬ãã«åäžã«ãå¯äžãããšèããããŸãã
ð æ¥åžžçæŽ»ã§å®è·µã§ããããš
ãã®ç ç©¶çµæãèžãŸããç§ãã¡äžäººã²ãšããæ¥åžžçæŽ»ã§ãã«ã¹ãªãã©ã·ãŒãé«ããå¥åº·ãå®ãããã«ã§ããããšãã玹ä»ããŸãã
- ä¿¡é Œã§ããæ å ±æºãèŠã€ããïŒåçåŽåçãåœç«ææçç ç©¶æãäžçä¿å¥æ©é¢ïŒWHOïŒãªã©ãå ¬çæ©é¢ãå°éæ©é¢ãçºä¿¡ããæ å ±ãåªå çã«ç¢ºèªããŸããããSNSãäžç¢ºããªæ å ±æºããã®æ å ±ã¯éµåã¿ã«ãããå¿ ãè£ä»ããåãç¿æ £ãã€ããŸãããã
- æ å ±ãçè§£ããããšåªããïŒé£ããå»ççšèªãåºãŠããããã€ã³ã¿ãŒãããã§æ€çŽ¢ãããããããã€ãå»ãè¬å€åž«ã«è³ªåãããããŠãå å®¹ãæ£ç¢ºã«çè§£ããããã«ããŸãããã
- å¥åº·ã«ã€ããŠç©æ¥µçã«è©±ãïŒå®¶æãå人ãå»çåŸäºè ãšå¥åº·ã«é¢ãã話é¡ãå ±æããçåã«æã£ãããšã¯é æ ®ãªã質åããŸãããã察話ãéããŠãããæ·±ãçè§£ãåŸãããããšããããŸãã
- èªèº«ã®å¥åº·ç¶æ ã«é¢å¿ãæã€ïŒå¥åº·èšºæã®çµæããã¡ããšç¢ºèªããèªåã®äœã®ç¶æ ãææ¡ããŸããããç æ°ã®ãªã¹ã¯ãäºé²çã«ã€ããŠåŠã³ãå¥åº·çãªçæŽ»ç¿æ £ãå¿ãããããšã倧åã§ãã
- äºé²è¡åãç¿æ £ã«ããïŒææŽãããã¹ã¯ççšïŒå¿ èŠã«å¿ããŠïŒããã©ã³ã¹ã®åããé£äºãé©åºŠãªéåãååãªç¡ç ãªã©ãåºæ¬çãªäºé²è¡åãæ¥ã ã®ç¿æ £ãšããŠç¶ç¶ããŸãããã
- å°åãã³ãã¥ããã£ã®æŽ»åã«åå ããïŒå°åã®å¥åº·æå®€ãã€ãã³ãã«åå ããããšã§ãæ°ããªå¥åº·æ å ±ãåŸãããåãç®çãæã€ä»²éãšäº€æµãããããæ©äŒãçãŸããŸãã
ð€ ç ç©¶ã®éçãšä»åŸã®èª²é¡
æ¬ç ç©¶ã¯éåžžã«éèŠãªç¥èŠããããããŸããããããã€ãã®éçãååšããŸãããããã®éçãçè§£ããããšã¯ãä»åŸã®ç ç©¶ãå®è·µãèããäžã§åœ¹ç«ã¡ãŸãã
- æºå®éšç ç©¶ã§ããããšïŒæ¬ç ç©¶ã¯ãåå è ãå®å šã«ã©ã³ãã ã«ä»å ¥çŸ€ãšå¯Ÿç §çŸ€ã«åãããã©ã³ãã 忝èŒè©Šéšãã§ã¯ãããŸããããã®ãããã°ã«ãŒãéã«æœåšçãªéãããã£ãå¯èœæ§ãå®å šã«æé€ããããšã¯ã§ããŸãããããå³å¯ãªå æé¢ä¿ã蚌æããããã«ã¯ãã©ã³ãã 忝èŒè©ŠéšãæãŸãããšãããŸãã
- 察象å°åã®é宿§ïŒç ç©¶ã¯ã¿ã€ã®ãã³ã³ã¯ãšããç¹å®ã®éœåžéšã®é«éœ¢è ã察象ãšããŠããŸãããã®ããããã®ããã°ã©ã ã®å¹æããä»ã®å°åïŒäŸãã°èŸ²æéšïŒãç°ãªãæåèæ¯ãæã€é«éœ¢è ã«ãåæ§ã«åœãŠã¯ãŸããã¯ããããªãæ€èšŒãå¿ èŠã§ãã
- èªå·±ç³ååŒã®è³ªå祚ïŒCOVID-19ãžã®æèãäºé²è¡åã¯ãåå è èªèº«ã®åçã«åºã¥ããŠè©äŸ¡ãããŸãããèªå·±ç³ååŒã®ããŒã¿ã«ã¯ãåçè ã瀟äŒçã«æãŸãããšèããè¡åãå ±åããåŸåïŒç€ŸäŒçæãŸãããã€ã¢ã¹ïŒãå«ãŸããå¯èœæ§ããããŸãã
- ããã°ã©ã æéïŒããã°ã©ã ã®ä»å ¥æéã¯æ¯èŒççãã远跡調æ»ã12é±éã§ãããé·æçãªå¹æã®æç¶æ§ã«ã€ããŠã¯ãããã«é·æéã«ããã远跡調æ»ãå¿ èŠãšãªãã§ãããã
ãããã®éçãèžãŸããä»åŸã¯ããå€§èŠæš¡ãªéå£ã察象ãšããç ç©¶ããç°ãªãå°åã»æåã§ã®æ€èšŒã客芳çãªææšãçšããè©äŸ¡ãªã©ã課é¡ãšããŠæããããŸããããããæ¬ç ç©¶ã瀺ãããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ã®æå¹æ§ã¯ãé«éœ¢è ã®å¥åº·å¢é²ã«åããéèŠãªäžæ©ãšãªãã§ãããã
ð ãŸãšã
ã¿ã€ã»ãã³ã³ã¯ã®é«éœ¢è ã察象ãšãããã®ç ç©¶ã¯ããã«ã¹ãªãã©ã·ãŒåäžããã°ã©ã ããCOVID-19ã«é¢ããæèãšäºé²è¡åãææã«æ¹åãããã®å¹æãããã°ã©ã çµäºåŸãæç¶ããããšãæããã«ããŸãããå€è§çãªã¢ãããŒããšå æ¬çãªãã«ã¹ãªãã©ã·ãŒã¢ãã«ã«åºã¥ããããã°ã©ã ã¯ãé«éœ¢è ãå¥åº·æ å ±ãçè§£ããé©åãªè¡åãéžæããèœåãé«ããäžã§éåžžã«æå¹ã§ãããã®ç¥èŠã¯ãçè·åž«ãäž»å°ããå°åããŒã¹ã®ä»å ¥ããéœåžéšã«äœãé«éœ¢è ã®å¥åº·ãå®ããå ¬è¡è¡çãåäžãããããã®åŒ·åãªããŒã«ãšãªãåŸãããšã瀺åããŠããŸããç§ãã¡äžäººã²ãšãããã«ã¹ãªãã©ã·ãŒãé«ããä¿¡é Œã§ããæ å ±ã«åºã¥ããŠè¡åããããšããèªåèªèº«ãšå€§åãªäººã®å¥åº·ãå®ãäžã§äžå¯æ¬ ã§ãã
é¢é£ãªã³ã¯é
- åçåŽåç
- åœç«ææçç ç©¶æ
- æ¥æ¬è幎å»åŠäŒ
- äžçä¿å¥æ©é¢ (WHO)
- ç±³åœçŸç 察çã»ã³ã¿ãŒ (CDC)
æžèªæ å ±
| DOI | 10.4040/jkan.25147 |
|---|---|
| PMID | 42687651 |
| PubMed URL | https://pubmed.ncbi.nlm.nih.gov/42687651/ |
| çºè¡å¹Ž | 2026 |
| èè å | Tupanich Walaya, Attaworakun Sasawan, Chaiyalap Suteekarn, Wattanawikan Nattanan |
| èè æå± | Kuakarun Faculty of Nursing, Navamindradhiraj University, Bangkok, Thailand.; Shinawatra University, Pathum Thani, Thailand. |
| éèªå | J Korean Acad Nurs |